Using advanced imaging to detect bile duct cancer early
Multispectral imaging of bile duct epithelial morphology for early detection of malignancy
This study is working on a new way to help doctors find bile duct cancer earlier and more accurately during routine check-ups, using a special light technology that makes it easier to spot any early signs of trouble without needing more invasive tests.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10944316 on NIH RePORTER |
What this research studies
This research focuses on improving the early detection of bile duct cancer, also known as cholangiocarcinoma, which is often lethal if not caught in time. The team is developing a new diagnostic technology that combines light scattering and diffuse reflectance spectroscopy to identify pre-cancerous and early cancerous changes in the bile duct during routine procedures. By using a specialized fiber optic probe, the goal is to scan the bile duct's internal surface more effectively and quickly, enhancing the accuracy of diagnosis without needing more invasive techniques. This innovative approach aims to provide a reliable method for detecting bile duct malignancies at an earlier stage.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for bile duct cancer or those undergoing procedures related to bile duct evaluation.
Not a fit: Patients with no symptoms or known risk factors for bile duct cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate detection of bile duct cancer, significantly improving patient outcomes.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for cancer detection, indicating potential success for this novel approach.
Where this research is happening
Boston, United States
- Beth Israel Deaconess Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Perelman, Lev T — Beth Israel Deaconess Medical Center
- Study coordinator: Perelman, Lev T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.